Rice University
George R. Brown School of Engineering
Department of Chemical & Biomolecular Engineering
Presents
Exploiting Liabilities of MetabolicallyChallenged Tumors
Dr. Eyal Gottlieb
Director, Cancer Metabolism
Research Unit
Cancer Research UK, Beatson
Institute
ABOUT THE SPEAKER: Professor Eyal Gottlieb, Ph.D. serves as a Member of Clinical Advisory Board at Dynamix
Pharmaceuticals Ltd. Prof. Gottlieb is a Professor of Molecular Cell Biology at the University of Glasgow and a
Research Group Leader at the Beatson Institute for Cancer Research in Glasgow. Prof. Gottlieb's studies focus on
cancer metabolism, combining analytic and organic chemistry with basic cancer research to explore new potential
clinical approaches for cancer treatment. Prof. Gottlieb graduated from The Hebrew University of Jerusalem, Israel,
and obtained a M Sc and a PhD from the Weizmann Institute of Science, Rehovot, Israel, where he studied the role
of the p53 transcription factor and tumor suppressor in apoptosis. Following that, he moved to the University of
Chicago as an EMBO Postdoctoral Fellow focusing on the metabolic roles of mitochondrial in apoptosis. He then
became a Special Fellow of the Leukemia and Lymphoma Society at the University of Pennsylvania, focusing on
cancer metabolism, before moving to the Beatson Institute for Cancer Research in Glasgow.
Thursday, March 19th, 2015
Herzstein Hall 212– 2:30 p.m.
SEMINAR SPONSOR BY CHEVRON